Eagle Pharmaceuticals Inc (EGRX)

Eagle Pharmaceuticals Inc Borsa (EGRX) Ultime notizie

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K

GlobeNewswire Inc.

Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio

GlobeNewswire Inc.

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

GlobeNewswire Inc.

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

GlobeNewswire Inc.

Eagle Pharmaceuticals Announces Management Change

GlobeNewswire Inc.

Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Zacks Investment Research

Top 4 Health Care Stocks That Could Blast Off This Quarter

Benzinga

Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Zacks Investment Research

Eagle Delays Third Quarter 2023 Results and Conference Call

GlobeNewswire Inc.

Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023

GlobeNewswire Inc.